Skip to main content
. 2019 Dec 13;25:9517–9523. doi: 10.12659/MSM.918126

Figure 1.

Figure 1

Receiver-operator characteristic (ROC) curve for the predictive level of serum calprotectin for major adverse cardiovascular events (MACE) in patients with diabetes who underwent percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS). The area under the curve (AUC) is 0.79, with a 95% confidence interval (95% CI) of 0.63–0.97.